1. Home
  2. MDGL vs BMI Comparison

MDGL vs BMI Comparison

Compare MDGL & BMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • BMI
  • Stock Information
  • Founded
  • MDGL 2011
  • BMI 1905
  • Country
  • MDGL United States
  • BMI United States
  • Employees
  • MDGL N/A
  • BMI N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • BMI Industrial Machinery/Components
  • Sector
  • MDGL Health Care
  • BMI Industrials
  • Exchange
  • MDGL Nasdaq
  • BMI Nasdaq
  • Market Cap
  • MDGL 9.6B
  • BMI 5.2B
  • IPO Year
  • MDGL N/A
  • BMI N/A
  • Fundamental
  • Price
  • MDGL $603.99
  • BMI $179.57
  • Analyst Decision
  • MDGL Strong Buy
  • BMI Buy
  • Analyst Count
  • MDGL 13
  • BMI 8
  • Target Price
  • MDGL $543.33
  • BMI $232.57
  • AVG Volume (30 Days)
  • MDGL 452.1K
  • BMI 308.0K
  • Earning Date
  • MDGL 11-04-2025
  • BMI 10-21-2025
  • Dividend Yield
  • MDGL N/A
  • BMI 0.90%
  • EPS Growth
  • MDGL N/A
  • BMI 16.37
  • EPS
  • MDGL N/A
  • BMI 4.69
  • Revenue
  • MDGL $740,640,000.00
  • BMI $901,139,000.00
  • Revenue This Year
  • MDGL $395.75
  • BMI $13.33
  • Revenue Next Year
  • MDGL $65.73
  • BMI $8.35
  • P/E Ratio
  • MDGL N/A
  • BMI $37.72
  • Revenue Growth
  • MDGL 864.21
  • BMI 12.11
  • 52 Week Low
  • MDGL $265.00
  • BMI $162.17
  • 52 Week High
  • MDGL $604.81
  • BMI $256.08
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 77.14
  • BMI 49.67
  • Support Level
  • MDGL $535.00
  • BMI $167.02
  • Resistance Level
  • MDGL $594.99
  • BMI $184.41
  • Average True Range (ATR)
  • MDGL 28.70
  • BMI 5.46
  • MACD
  • MDGL 7.02
  • BMI 0.03
  • Stochastic Oscillator
  • MDGL 99.09
  • BMI 48.48

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BMI Badger Meter Inc.

Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has global operations, with the vast majority of revenue derived from the US.

Share on Social Networks: